4.1 Article

Effects of Clozapine on Heart Rate Dynamics and Their Relationship With Therapeutic Response in Treatment-Resistant Schizophrenia

Journal

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
Volume 33, Issue 1, Pages 69-73

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/JCP.0b013e31827d14e3

Keywords

clozapine; heart rate variability; nonlinear complexity measures; treatment response

Funding

  1. Ministry of Health & Welfare, Republic of Korea [A070001]
  2. Gil Hospital Research Fund
  3. Merck
  4. Otsuka
  5. Roche
  6. Novartis
  7. Janssen
  8. Eli Lilly
  9. Pfizer
  10. Sanofi-Aventis
  11. AstraZeneca
  12. GlaxoSmithKline
  13. Servier

Ask authors/readers for more resources

Previous studies have suggested the utility of nonlinear complexity measures of heart rate variability (HRV) in evaluating the regulatory capacity of the neuroautonomic system. The purpose of the present study was to investigate the effects of clozapine on the nonlinear complexity measures of HRV in patients with treatment-resistant schizophrenia to find novel electrophysiological markers that indicate response to clozapine treatment. Forty patients with treatment-resistant schizophrenia were evaluated during 8 weeks of clozapine monotherapy. For nonlinear complexity measures of HRV, the approximate entropy (ApEn) and sample entropy (SampEn) values were obtained. The response rate to clozapine was 37.5%. The results of multivariate analysis of covariance revealed that the ApEn and the SampEn values of HRV at week 8 were significantly higher in the responders than in the nonresponders. Repeated-measures analysis of covariance showed a significant group by time interaction effect in the ApEn and SampEn indices. The responder group showed an increasing pattern of change in these complexity measures after administration of clozapine, whereas the nonresponder group showed a decreasing pattern of change. These results suggest that the nonlinear dynamic complexity measures of HRV, which indicate the irregularity and complexity of the biosystem, may be useful in evaluating the therapeutic changes of neuroautonomic function in schizophrenia. The response to clozapine treatment is expected to be more favorable when the plasticity of the neuroautonomic system reflected in the nonlinear complexity measures is high.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available